Sunil Patel Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sunil Patel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sunil Patel. Sunil Patel is Director in LIGAND PHARMACEUTICALS INC ($LGND) and See Remarks in OncoMed Pharmaceuticals Inc ($OMED) and SVP & Chief Financial Officer in OncoMed Pharmaceuticals Inc ($OMED).
Latest Insider Trading Transactions of Sunil Patel
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Grant | A | 0.00 | 630 | 0 | 28,820 | 28.2 K to 28.8 K (+2.23 %) |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Grant | A | 0.00 | 630 | 0 | 28,820 | 28.2 K to 28.8 K (+2.23 %) |
Nov 04 2020 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | P | 82.52 | 1,000 | 82,520 | 28,190 | 27.2 K to 28.2 K (+3.68 %) |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | A | 117.58 | 2,468 | 290,187 | 2,468 | |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Grant | A | 0.00 | 831 | 0 | 27,190 | 26.4 K to 27.2 K (+3.15 %) |
Aug 05 2019 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | P | 95.98 | 1,000 | 95,980 | 26,359 | 25.4 K to 26.4 K (+3.94 %) |
Jun 07 2019 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | A | 113.59 | 4,071 | 462,425 | 4,071 | |
Jun 07 2019 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Grant | A | 0.00 | 835 | 0 | 25,359 | 24.5 K to 25.4 K (+3.40 %) |
Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | M | 32.30 | 7,335 | 236,921 | 0 | |
Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | M | 12.53 | 7,335 | 91,908 | 0 | |
Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | M | 10.12 | 7,335 | 74,230 | 0 | |
Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | M | 9.60 | 5,000 | 48,000 | 0 | |
Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Sell | S | 240.05 | 42,287 | 10,150,808 | 24,524 | 66.8 K to 24.5 K (-63.29 %) |
Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | M | 32.30 | 7,335 | 236,921 | 66,811 | 59.5 K to 66.8 K (+12.33 %) |
Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | M | 12.53 | 7,335 | 91,908 | 59,476 | 52.1 K to 59.5 K (+14.07 %) |
Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | M | 10.12 | 7,335 | 74,230 | 52,141 | 44.8 K to 52.1 K (+16.37 %) |
Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | M | 9.60 | 5,000 | 48,000 | 44,806 | 39.8 K to 44.8 K (+12.56 %) |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Grant | A | 0.00 | 493 | 0 | 39,806 | 39.3 K to 39.8 K (+1.25 %) |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Grant | A | 0.00 | 493 | 0 | 39,806 | 39.3 K to 39.8 K (+1.25 %) |
Jan 08 2018 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Option Exercise | A | 3.98 | 100,000 | 398,000 | 100,000 | |
Oct 12 2017 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Sell | S | 4.24 | 1,202 | 5,099 | 68,336 | 69.5 K to 68.3 K (-1.73 %) |
Oct 12 2017 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Sell | S | 4.27 | 46 | 196 | 69,538 | 69.6 K to 69.5 K (-0.07 %) |
Oct 10 2017 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Option Exercise | A | 4.36 | 50,000 | 218,000 | 50,000 | |
Oct 10 2017 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Grant | A | 0.00 | 25,000 | 0 | 69,584 | 44.6 K to 69.6 K (+56.07 %) |
May 26 2017 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | A | 113.50 | 2,456 | 278,756 | 2,456 | |
May 26 2017 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Grant | A | 0.00 | 666 | 0 | 39,313 | 38.6 K to 39.3 K (+1.72 %) |
Apr 25 2017 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Option Exercise | A | 3.73 | 60,000 | 223,800 | 60,000 | |
Apr 25 2017 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Grant | A | 0.00 | 20,000 | 0 | 44,584 | 24.6 K to 44.6 K (+81.35 %) |
Apr 05 2017 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Sell | S | 9.06 | 5,711 | 51,731 | 24,584 | 30.3 K to 24.6 K (-18.85 %) |
Apr 05 2017 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Sell | S | 8.87 | 43 | 382 | 30,295 | 30.3 K to 30.3 K (-0.14 %) |
Jan 05 2017 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Option Exercise | A | 7.66 | 65,000 | 497,900 | 65,000 | |
Oct 11 2016 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Grant | A | 0.00 | 12,500 | 0 | 30,338 | 17.8 K to 30.3 K (+70.08 %) |
May 25 2016 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | A | 119.30 | 2,329 | 277,850 | 2,329 | |
May 25 2016 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Grant | A | 0.00 | 622 | 0 | 38,647 | 38 K to 38.6 K (+1.64 %) |
Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Sell | S | 21.33 | 1 | 21 | 17,838 | 17.8 K to 17.8 K (-0.01 %) |
Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Sell | S | 21.65 | 69 | 1,494 | 17,839 | 17.9 K to 17.8 K (-0.39 %) |
Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Sell | S | 22.30 | 2,092 | 46,653 | 17,908 | 20 K to 17.9 K (-10.46 %) |
Dec 29 2015 | OMED | OncoMed Pharmaceut ... | Patel Sunil | SVP & Chief Financi ... | Option Exercise | A | 21.43 | 70,000 | 1,500,100 | 70,000 | |
Apr 27 2015 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | A | 89.75 | 2,754 | 247,172 | 2,754 | |
Apr 27 2015 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Grant | A | 0.00 | 925 | 0 | 38,025 | 37.1 K to 38 K (+2.49 %) |
Mar 23 2015 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Option Exercise | M | 3.42 | 14,665 | 50,154 | 101,595 | |
Mar 23 2015 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Option Exercise | M | 3.42 | 3,335 | 11,406 | 116,260 | |
Mar 23 2015 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Sell | S | 27.86 | 14,665 | 408,543 | 20,000 | 34.7 K to 20 K (-42.30 %) |
Mar 23 2015 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Buy | M | 3.42 | 14,665 | 50,154 | 34,665 | 20 K to 34.7 K (+73.33 %) |
Mar 23 2015 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Sell | S | 27.34 | 3,335 | 91,186 | 20,000 | 23.3 K to 20 K (-14.29 %) |
Mar 23 2015 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Buy | M | 3.42 | 3,335 | 11,406 | 23,335 | 20 K to 23.3 K (+16.68 %) |
Mar 20 2015 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Sell | S | 74.42 | 4,591 | 341,662 | 37,100 | 41.7 K to 37.1 K (-11.01 %) |
Page: 1